Manx Healthcare

Taylor Group House, Wedgnock Lane, Warwick, Warwickshire, CV34 5YA
Telephone: +44 (0)1926 482 511
Fax: +44 (0)1926 498 711
Summary of Product Characteristics last updated on the eMC: 28/10/2008
SPC Midrid Capsules 15s

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/10/2008 and displayed until Current
Reasons for adding or updating:
  • Change to section 6.2 - Incompatibilities
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 6. 5 - Nature and Contents of Container
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and Lactation
  • Change to section 4.8 - Undesirable Effects
  • Change to section 4.9 - Overdose
  • Change to section 5.2 - Pharmacokinetic Properties
Date of revision of text on the SPC:   01-Apr-2008
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 4.3
First line of text clarified

Section 4.4
Para 2 change from 'administration of paracetamol' to 'administration of product'
Inclusion of 'sight' in the KOOROC warning

Section 4.5
Addition of interactions with bromocriptine with isometheptene; and increased risk of a hypertensive crisis when sympathomimetics are given with MAOIs

Section 4.6
Addition of 'avoid in lactation' in last sentence

Section 4.8
Totally updated

Section 4.9
Totally updated

Section 5.2
Correction of 'accounts' to 'amounts' in first sentence, 3rd para

Section 6.2
Amended to 'not applicable'

Section 6.4
Storage condition updated to current used terminology

Section 6.5
Securitainers deleted from SPC

Section 9
Renewal date added
Updated on 26/09/2008 and displayed until 28/10/2008
Reasons for adding or updating:
  • Change to MA holder contact details
Date of revision of text on the SPC:   11-Apr-2008
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Updated MA holder address to:
Taylor Group House
Wedgnock Lane
Warwick
CV34 5YA
Updated on 29/09/2006 and displayed until 26/09/2008
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 01/01/0001 and displayed until 29/09/2006
Reasons for adding or updating:
  • No reasons supplied
Updated on 19/12/2000 and displayed until 01/01/0001
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 19/12/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   paracetamol
   isometheptene mucate


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk